Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:DFFNNASDAQ:FBLGNASDAQ:HOWLNASDAQ:RMTI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDFFNDiffusion Pharmaceuticals$4.64$2.76▼$7.40$8.98M1.7810,937 shs351,000 shsFBLGFibroBiologics$0.70-3.1%$0.93$0.70▼$6.12$26.61M-0.79299,042 shs307,259 shsHOWLWerewolf Therapeutics$1.19-4.0%$1.07$0.60▼$4.18$53.40M0.65443,093 shs282,065 shsRMTIRockwell Medical$0.89-5.3%$1.03$0.86▼$5.15$30.42M1.61419,780 shs285,067 shs13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDFFNDiffusion Pharmaceuticals0.00%0.00%0.00%0.00%0.00%FBLGFibroBiologics0.00%-13.99%-19.12%-37.33%-88.78%HOWLWerewolf Therapeutics0.00%-2.46%+7.21%+5.31%-58.82%RMTIRockwell Medical0.00%-5.32%-10.71%-34.07%-51.89%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationDFFNDiffusion PharmaceuticalsN/AN/AN/AN/AN/AN/AN/AN/AFBLGFibroBiologics3.0599 of 5 stars3.64.00.00.01.72.50.6HOWLWerewolf Therapeutics3.0683 of 5 stars3.53.00.00.00.65.00.6RMTIRockwell Medical4.381 of 5 stars3.75.00.04.11.51.70.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDFFNDiffusion Pharmaceuticals 0.00N/AN/AN/AFBLGFibroBiologics 3.20Buy$13.001,768.89% UpsideHOWLWerewolf Therapeutics 3.00Buy$8.33600.28% UpsideRMTIRockwell Medical 3.33Buy$4.00349.44% UpsideCurrent Analyst Ratings BreakdownLatest DFFN, HOWL, FBLG, and RMTI Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/17/2025FBLGFibroBiologicsD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$16.005/15/2025FBLGFibroBiologicsD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$16.00 ➝ $16.005/9/2025HOWLWerewolf TherapeuticsWedbushSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$8.00 ➝ $6.004/9/2025FBLGFibroBiologicsD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$16.00 ➝ $16.004/1/2025FBLGFibroBiologicsD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$16.00 ➝ $16.004/1/2025FBLGFibroBiologicsHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$12.00 ➝ $12.003/24/2025RMTIRockwell MedicalHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$7.00 ➝ $3.00(Data available from 6/22/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDFFNDiffusion PharmaceuticalsN/AN/AN/AN/A$6.97 per shareN/AFBLGFibroBiologicsN/AN/AN/AN/A$0.08 per shareN/AHOWLWerewolf Therapeutics$1.88M28.40N/AN/A$1.65 per share0.72RMTIRockwell Medical$101.49M0.30$0.13 per share7.04$1.01 per share0.88Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDFFNDiffusion Pharmaceuticals-$15.59MN/A0.00N/AN/AN/A-69.96%-62.98%N/AFBLGFibroBiologics-$11.16M-$0.21N/AN/AN/AN/A-1,022.04%-117.56%8/6/2025 (Estimated)HOWLWerewolf Therapeutics-$70.51M-$1.67N/AN/AN/AN/A-89.37%-54.87%8/14/2025 (Estimated)RMTIRockwell Medical-$480K-$0.02N/AN/AN/A-0.27%-0.90%-0.47%8/6/2025 (Estimated)Latest DFFN, HOWL, FBLG, and RMTI EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/13/2025Q1 2025FBLGFibroBiologics-$0.10-$0.14-$0.04-$0.14N/AN/A5/12/2025Q1 2025RMTIRockwell Medical-$0.03-$0.04-$0.01-$0.04$17.46 million$18.91 million5/8/2025Q1 2025HOWLWerewolf Therapeutics-$0.44-$0.40+$0.04-$0.40$0.30 millionN/A3/31/2025Q4 2024FBLGFibroBiologics-$0.10-$0.09+$0.01-$0.09N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDFFNDiffusion PharmaceuticalsN/AN/AN/AN/AN/AFBLGFibroBiologicsN/AN/AN/AN/AN/AHOWLWerewolf TherapeuticsN/AN/AN/AN/AN/ARMTIRockwell MedicalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDFFNDiffusion PharmaceuticalsN/A10.7110.71FBLGFibroBiologicsN/A1.141.14HOWLWerewolf Therapeutics0.468.098.09RMTIRockwell Medical0.302.952.50Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDFFNDiffusion Pharmaceuticals9.95%FBLGFibroBiologicsN/AHOWLWerewolf Therapeutics64.84%RMTIRockwell Medical23.31%Insider OwnershipCompanyInsider OwnershipDFFNDiffusion Pharmaceuticals1.80%FBLGFibroBiologics20.80%HOWLWerewolf Therapeutics23.60%RMTIRockwell Medical1.90%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDFFNDiffusion Pharmaceuticals132.04 million2.00 millionNot OptionableFBLGFibroBiologics1038.26 million30.30 millionN/AHOWLWerewolf Therapeutics4044.87 million34.28 millionOptionableRMTIRockwell Medical30034.17 million33.53 millionOptionableDFFN, HOWL, FBLG, and RMTI HeadlinesRecent News About These CompaniesRockwell Medical (NASDAQ:RMTI) Rating Increased to Hold at Wall Street ZenJune 16, 2025 | americanbankingnews.comBuy Rating for Rockwell Medical Amid Growth Potential and Market PositioningMay 19, 2025 | tipranks.comEarnings call transcript: Rockwell Medical Q1 2025 beats EPS forecast, stock jumpsMay 13, 2025 | uk.investing.comRockwell Medical, Inc. (NASDAQ:RMTI) Q1 2025 Earnings Call TranscriptMay 13, 2025 | msn.comQ1 2025 Rockwell Medical Inc Earnings CallMay 13, 2025 | finance.yahoo.comRockwell Medical Inc (RMTI) Q1 2025 Earnings Call Highlights: Navigating Challenges and ...May 13, 2025 | gurufocus.comQ1 2025 Rockwell Medical Inc Earnings Call TranscriptMay 13, 2025 | gurufocus.comRockwell Medical’s Earnings Call: Navigating TransitionMay 12, 2025 | tipranks.comRockwell Medical, Inc. (RMTI) Q1 2025 Earnings Call TranscriptMay 12, 2025 | seekingalpha.comRockwell Medical (RMTI) Reports Q1 Loss, Tops Revenue EstimatesMay 12, 2025 | zacks.comRockwell Medical Announces First Quarter 2025 ResultsMay 12, 2025 | businesswire.comRockwell Medical (RMTI) Q1 Revenue Exceeds Expectations Despite Sales DipMay 12, 2025 | gurufocus.comRockwell Medical Announces First Quarter 2025 Results | RMTI Stock NewsMay 12, 2025 | gurufocus.comRockwell Medical Inc Q1 2025 Earnings: EPS of -$0.05 Meets Estimates, Revenue of $18. ...May 12, 2025 | gurufocus.comRockwell Medical, Inc. (NASDAQ:RMTI) Major Shareholder Larson Family Inve Irrevocable Buys 57,000 SharesApril 16, 2025 | insidertrades.comRockwell Medical Investment Trust buys shares worth $94,017April 15, 2025 | investing.comRockwell Medical to Release First Quarter 2025 Results on Monday, May 12, 2025April 14, 2025 | gurufocus.comRockwell Medical to Release First Quarter 2025 Results on Monday, May 12, 2025 | RMTI Stock NewsApril 14, 2025 | gurufocus.comRockwell Medical to Release First Quarter 2025 Results on Monday, May 12, 2025April 14, 2025 | businesswire.comRockwell Medical stock target cut to $3 at H.C. WainwrightMarch 26, 2025 | investing.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeDFFN, HOWL, FBLG, and RMTI Company DescriptionsDiffusion Pharmaceuticals NASDAQ:DFFNDiffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissues, as well as to treat COVID-19 disease. The company was founded in 2001 and is based in Charlottesville, Virginia.FibroBiologics NASDAQ:FBLG$0.70 -0.02 (-3.12%) Closing price 06/20/2025 04:00 PM EasternExtended Trading$0.72 +0.02 (+3.51%) As of 06/20/2025 07:12 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.FibroBiologics, Inc. operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. It holds 150+ U.S. and internationally issued patents/patents pending across various clinical pathways, including disc degeneration, orthopedics, multiple sclerosis, psoriasis, wound healing, reversing organ involution, and cancer. FibroBiologics, Inc. was incorporated in 2021 and is based in Houston, Texas.Werewolf Therapeutics NASDAQ:HOWL$1.19 -0.05 (-4.03%) Closing price 06/20/2025 04:00 PM EasternExtended Trading$1.23 +0.04 (+2.94%) As of 06/20/2025 06:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional proinflammatory immune therapies. Its lead product candidates are WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule that is in Phase I/Ib clinical trial for the treatment of advanced or metastatic solid tumors; and WTX-330, a conditionally activated Interleukin-12 INDUKINE molecule, which is in Phase I clinical trial for the treatment of advanced or metastatic solid tumors and lymphoma. The company is also developing JZP898, a conditionally activated interferon alpha INDUKINE molecule for the treatment of cancer; and WTX-712, an activated Interleukin-21(IL-21) and WTX-518, an activated IL-18 (IL-18) INDUKINE molecule for the treatment of cancer. Werewolf Therapeutics, Inc. was incorporated in 2017 and is headquartered in Watertown, Massachusetts.Rockwell Medical NASDAQ:RMTI$0.89 -0.05 (-5.32%) Closing price 06/20/2025 04:00 PM EasternExtended Trading$0.91 +0.02 (+2.25%) As of 06/20/2025 07:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Rockwell Medical, Inc., together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including testing supplies, 5% acetic acid cleaning solution, 5% and 2% citric acid descaler, filtration salts, and other items used by hemodialysis providers. The company's hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream. The company serves to hemodialysis clinics. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas New All-Time Highs Coming for Broadcom? Wall Street Says Yes Smith & Wesson Stock Falls on Earnings Miss, Tariff Woes Marvell's New AI Chip Deals Capture Wall Street’s Attention Super Micro Computer Stock's Rally Backed by Strong Financials Forget the Fed: Home Depot Is the Real Gauge of the U.S. Consumer GE Aerospace Turns Engines Into Long-Term Profits 3 Reasons AMD Could Be the Hottest Stock of the Summer Analysts Keep Boosting Taiwan Semiconductor Stock—Here's Why Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
